Takeaway

• A network meta-analysis was used to compare adjuvant therapies for early-stage (stages I-III) resected triple-negative breast cancer (TNBC).
• It finds that only 1 regimen—the addition of capecitabine to anthracycline and taxane-based chemotherapy—is effective for OS.
• 6 regimens are found to be most effective for DFS, with carboplatin/paclitaxel coming out...